Name | Number of supported studies | Average coverage | |
---|---|---|---|
natural killer cell | 11 studies | 23% ± 8% | |
CD16-positive, CD56-dim natural killer cell, human | 11 studies | 30% ± 14% | |
regulatory T cell | 9 studies | 20% ± 4% | |
CD8-positive, alpha-beta T cell | 3 studies | 25% ± 7% | |
mature NK T cell | 3 studies | 30% ± 12% |
Insufficient scRNA-seq data for expression of LAIR2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 86% | 17.49 | 497 / 578 | 49% | 2.73 | 563 / 1155 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.54 | 1 / 1 |
spleen | 98% | 27.00 | 237 / 241 | 0% | 0 | 0 / 0 |
intestine | 41% | 4.07 | 399 / 966 | 53% | 2.03 | 279 / 527 |
peripheral blood | 89% | 69.40 | 826 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 76% | 4.23 | 22 / 29 |
bladder | 33% | 1.38 | 7 / 21 | 40% | 1.69 | 202 / 504 |
stomach | 18% | 1.33 | 66 / 359 | 54% | 2.99 | 154 / 286 |
thymus | 34% | 3.58 | 220 / 653 | 34% | 0.87 | 207 / 605 |
breast | 38% | 3.42 | 176 / 459 | 25% | 0.85 | 282 / 1118 |
tonsil | 0% | 0 | 0 / 0 | 62% | 1.42 | 28 / 45 |
esophagus | 18% | 1.31 | 255 / 1445 | 43% | 1.79 | 79 / 183 |
pancreas | 5% | 0.38 | 15 / 328 | 51% | 1.65 | 90 / 178 |
kidney | 22% | 3.93 | 20 / 89 | 27% | 1.48 | 247 / 901 |
uterus | 13% | 0.66 | 22 / 170 | 37% | 1.54 | 168 / 459 |
adipose | 46% | 7.00 | 551 / 1204 | 0% | 0 | 0 / 0 |
liver | 26% | 1.94 | 58 / 226 | 17% | 0.72 | 70 / 406 |
skin | 8% | 0.45 | 149 / 1809 | 30% | 1.04 | 142 / 472 |
brain | 31% | 4.40 | 807 / 2642 | 6% | 0.22 | 44 / 705 |
prostate | 26% | 1.52 | 63 / 245 | 11% | 0.20 | 53 / 502 |
adrenal gland | 21% | 1.59 | 53 / 258 | 4% | 0.49 | 10 / 230 |
blood vessel | 19% | 1.84 | 252 / 1335 | 0% | 0 | 0 / 0 |
heart | 17% | 0.98 | 143 / 861 | 0% | 0 | 0 / 0 |
ovary | 8% | 0.51 | 15 / 180 | 7% | 0.12 | 30 / 430 |
muscle | 8% | 0.38 | 63 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.04 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002764 | Biological process | immune response-regulating signaling pathway |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | LAIR2 |
Protein name | Leukocyte-associated immunoglobulin-like receptor 2 Leukocyte-associated immunoglobulin-like receptor 2 (LAIR-2) (CD antigen CD306) |
Synonyms | CD306 |
Description | |
Accessions | ENST00000611580.4 ENST00000618103.4 A0A0G2JLQ0 ENST00000613846.4 ENST00000412608.5 ENST00000622161.1 ENST00000622556.4 [Q6ISS4-1] ENST00000621280.1 [Q6ISS4-2] ENST00000621365.4 Q6ISS4 A0A087X1V4 C9JFQ0 ENST00000351841.2 [Q6ISS4-2] A0A0G2JN10 ENST00000621509.1 ENST00000620256.4 [Q6ISS4-2] ENST00000622782.4 ENST00000613910.4 ENST00000610651.1 A0A0G2JMB1 A0A0G2JPH6 ENST00000301202.7 [Q6ISS4-1] ENST00000612901.4 [Q6ISS4-1] |